Navigation Links
Boston Scientific Announces CEO Jim Tobin to Extend Tenure
Date:6/3/2008

Company announces management changes and further organizational

consolidation

Fred Colen to lead CRM group

Paul LaViolette to retire from Company

NATICK, Mass., June 3 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) announced today that President and Chief Executive Officer Jim Tobin will be extending his tenure at the Company. The Company said Tobin plans to remain in his role for the foreseeable future.

The Company also announced that Fred Colen will become the President of its Cardiac Rhythm Management (CRM) group, and that Paul LaViolette, Chief Operating Officer (COO), will be retiring from the Company.

Colen has been with the Company since 1999 in a number of leadership positions. Most recently, he has served as Executive Vice President, Operations and Technology, CRM. Prior to this role, he served as Executive Vice President and Chief Technology Officer for the Company.

LaViolette first joined the Company in 1994, and he has also served in a number of leadership positions. He has been COO since 2005.

"I am very pleased to announce that Jim Tobin will be extending his tenure as President and Chief Executive Officer of Boston Scientific," said Pete Nicholas, Co-founder and Chairman of the Board of Boston Scientific. "Two years ago we announced a similar extension. During the intervening time, Jim has devoted the majority of his attention to the integration of Guidant, while Paul has managed much of the day-to-day operations of the rest of the Company. After two years of Jim's intense focus and successful leadership, our CRM business and its new management team are re-vitalized and well positioned to
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update
2. Boston Scientific Completes Acquisition of CryoCor
3. Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protection System
4. Boston Scientific Announces FDA Approval of New Heart Failure Lead
5. Boston Scientifics SpyGlass(R) Direct Visualization System to Be Prominently Featured at Digestive Disease Week(R)
6. Boston Scientific Announces Program to Analyze Latitude(R) Patient Monitoring Data
7. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
8. WIPO Panel Rules Boston Scientific Liberte(R) and TAXUS(R) Liberte(R) Stents Do Not Infringe Medinol Patents
9. Fraunhofer and Boston University Hosted Prestigious SME Tour
10. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
11. Boston Scientific Announces Results for First Quarter Ended March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 19, 2014 Naurex Inc., a ... drugs for diseases of the central nervous system, today ... chief executive officer, will present at the 33 rd ... will take place at 3:00 p.m. PST on Tuesday, ... San Francisco, Calif. ...
(Date:12/19/2014)... , Dec. 19, 2014 Decision Resources ... will grow at a 12 percent compound annual growth ... of the aging population and the increasing adoption of ... America will also spur demand for dental ... dental implant and periodontal treatments. Other key ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 Today, ... locate its pilot production facility and future company ... and produce innovative new materials that safely and ... not only because of its historic, strong support ... efforts to attract leading edge, technology-based companies such ...
(Date:12/19/2014)... Reports from CDC show approximately ... one or more chronic health conditions - including cardiovascular ... some of these diseases, but may not eliminate the ... While implanted nerve stimulation devices today offer relief, they ... can induce side effects. , To eliminate the ...
Breaking Biology Technology:Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2
... Calif., June 3 Ingenuity Systems, the,leading provider ... signing of a four year agreement with Boehringer ... used throughout the,Boehringer Ingelheim research and development organization ... a general tool for biological search,and exploration., ...
... N.C. -- Microscopic robots crafted to maneuver separately without ... after years of continuing research led by a Duke ... to do assembly and control at this fine a ... Donald, a Duke professor of computer science and biochemistry. ...
... 2 Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) ... data,for its FDA-approved diabetes drugs, BYETTA(R) (exenatide) injection ... and,obesity drug candidates at the American Diabetes Association,s ... Francisco, CA from June 6 to,10. The company ...
Cached Biology Technology:Ingenuity Systems Announces Multi-Year Agreement With Boehringer Ingelheim 2Microrobots dance on something smaller than a pin's head 2Microrobots dance on something smaller than a pin's head 3Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 2Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 3Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 4Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 5Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 6Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 7
(Date:12/11/2014)... 10, 2014  Data Sciences International (DSI), the ... a new series of digital telemetry implants to ... M series, part of the PhysioTel™ Digital platform, ... possible physiologic data when incorporating functional endpoints into ... to toxicology studies has evolved from short ECG ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
(Date:12/10/2014)... , December 9, 2014 ... BCARD Platform   ... meeting scheduling solutions for business-to-business (B2B) events, today ... leader in mobile near-field communication (NFC), Bluetooth low ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3
... for killer diseases such as HIV/AIDS, TB, Malaria, Chagas ... is despite the fact that these diseases mainly affect ... is inhibitive due to lack of economic demand. Researchers ... of some vaccines and diagnostics) would increase if more ...
... hand-in-hand with enlargement of a brain region that handles negative ... Texas Veterans Health Care System have found. , ... and contains more nerve cells in humans who carry the ... regions that receive input from the pulvinar are more strongly ...
... have limited lifespans, which means that they must be ... into the blood cell types needed by the body. ... Molecular Biology Laboratory (EMBL) unit in Monterotondo, Italy, in ... the University of Lund in Sweden, have now uncovered ...
Cached Biology News:Increase in drug development for killer diseases is not enough 2Gene linked with mental illness shapes brain region, researchers find 2Lost in the labyrinth 2
... SpeedVac™ Concentrators set the standard for sample concentration ... with large chamber uses a combination of centrifugal ... in a single run. , SC210A comes equipped ... for long lasting chemical compatibility ...
Digital display of time, vacuum and temperature , Dual vacuum control of ramping rate and ultimate level , Comes complete with RH40-12 (40 x 1.5 ml) Rotor and (2) Glass Condensation Flasks. ...
... series of vacuum concentrators/centrifugal evaporators offers a ... to rapid and safe concentration of heat-labile ... with oil-free or high vacuum pumps, a ... selection of rotors (eliminating sample loss by ...
... George Paxinos Affiliation: School of Psychology, The University ... Affiliation: Curtin University of Technology, Perth, Australia This ... of the rat brain. It is a ... revison and extension of the compact 3rd edition. ...
Biology Products: